RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells.
Ontology highlight
ABSTRACT: Cancer cells typically experience higher oxidative stress than normal cells, such that elevating pro-oxidant levels can trigger cancer cell death. Although pre-exposure to mild oxidative agents will sensitize cancer cells to radiation, this pre-exposure may also activate the adaptive stress defense system in normal cells. Ascorbic acid is a prototype redox modulator that when infused intravenously appears to kill cancers without injury to normal tissues; however, the mechanisms involved remain elusive. In this study, we show how ascorbic acid kills cancer cells and sensitizes prostate cancer to radiation therapy while also conferring protection upon normal prostate epithelial cells against radiation-induced injury. We found that the NF-κB transcription factor RelB is a pivotal determinant
SUBMITTER: Wei X
PROVIDER: S-EPMC5354963 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA